Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RAB17 |
| Upstream (Parents) |
|---|
| (<<) PRODH2 → RAB17 |
| (<<) SORD → RAB17 |
| Downstream (Children) |
|---|
| RAB17 → ASL (>>) |
| RAB17 → SLC25A15 (>>) |
| RAB17 → CST6 (>>) |
| RAB17 → HCFC1R1 (>>) |
| RAB17 → LMOD1 (>>) |
| RAB17 → CYP2A13 (>>) |
| RAB17 → NCS1 (>>) |
| RAB17 → GJB1 (>>) |
| RAB17 → NIPSNAP1 (>>) |
| RAB17 → WARS (>>) |
| RAB17 → NSUN6 (>>) |
| RAB17 → NUDT13 (>>) |
